Clinical Trial Update: Effect of Ensifentrine Treatment on CAT Score [Phase 3]

View source ↗

Summary

Phase 3 trial assessing ensifentrine's effect on the COPD CAT score has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ensifentrine (ensifentrine)

Snippet

Sponsor: Verona Pharma plc | Conditions: COPD | Phase 3 | Status: COMPLETED | Results posted: 2025-04-18